The Tech Rotation Is On and Dividend-Paying Blue-Chips Are the Winners
These six top blue-chip dividend stocks remain outstanding ideas for investors seeking to move away from tech stocks.
These six top blue-chip dividend stocks remain outstanding ideas for investors seeking to move away from tech stocks.
With the Federal Reserve likely to continue lowering rates until next summer, now is the time to load the boat on five of our favorite blue-chip dividend giants.
These five high-yield dividend stocks are the kind that Baby Boomers and retirees can buy and own with confidence.
There’s no better way to generate passive income than dividend stocks. If a stock has a dividend yield higher than the common benchmark, such as the S&P 500, it could be a…
Following in the footsteps of David Solomon at Goldman Sachs and Jamie Dimon at JPMorgan, Ark Investments guru Cathie Wood recently warned of the potential for a reality check for the stock…
These five top dividend stock picks are waiting for growth and income investors to step up to the plate. Plus, they are rated Buy at top firms on Wall Street
With the bull market starting its fourth year, and yields on U.S. debt falling to the lowest levels since early this year, many growth and income investors have begun to look for…
UnitedHealth Group (NYSE:UNH | UNH Price Prediction), Bristol-Myers Squibb (NYSE:BMY) and Fiserv (NYSE:FI) have been getting plenty of attention from big name investors. Every three months, the SEC’s 13F filings open a small window…
Five quality companies have at least a 5% dividend, are Buy-rated at top Wall Street firms, and are perfect candidates for a buy-and-hold portfolio.
September has a habit of making investors glance twice at their statements. The post-summer calm often gives way to choppy price swings, and this year, it’s increasingly tempting to seek refuge in…
Five high-yield stocks of well-run companies look like timely buys now for savvy Baby Boomers and retirees seeking safe income ideas.
Live Updates Thursday Wrap-up4:07pm ETThe Vanguard S&P 500 ETF closed Thursday at 580.95, down 0.4% for the day. Investors Give Bristol-Myers the Cold Shoulder After Earnings Beat11:46am ETPharmaceuticals giant Bristol-Myers Squibb (NYSE: BMY |…
Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.
Watch the Video Transcript: Douglas: Lee, at this point in the year, all the companies that pay dividends have pretty much set their dividends. You know, the boards have their share buybacks,…
Four well-known dividend stocks are ideal choices for growth and income investors seeking reliable passive income with some growth potential to keep pace with inflation.